Escherichia Coli Trivalent Vaccine for Piglets Market

Escherichia Coli Trivalent Vaccine for Piglets is used to prevent diarrhea in newborn piglets caused by Escherichia coli. Inoculation of sows in late pregnancy, newborn piglets obtain maternal antibodies through colostrum.
Escherichia Coli Trivalent Vaccine for Piglets Market contains market size and forecasts of Escherichia Coli Trivalent Vaccine for Piglets in global, including the following market information:
Global Escherichia Coli Trivalent Vaccine for Piglets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Escherichia Coli Trivalent Vaccine for Piglets Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Escherichia Coli Trivalent Vaccine for Piglets companies in 2021 (%)
The global Escherichia Coli Trivalent Vaccine for Piglets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10ml/bottle Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Escherichia Coli Trivalent Vaccine for Piglets include Qilu Animal Health, Shanghai Hile Bio-Technology Co., Ltd., CAHIC, Shandong Huahong Biological Engineering Co., Ltd., Zhejiang Nuobewei Biotechnology Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd. and Shandong Binzhou Wohua Biological Engineering Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Escherichia Coli Trivalent Vaccine for Piglets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Escherichia Coli Trivalent Vaccine for Piglets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Escherichia Coli Trivalent Vaccine for Piglets Market Segment Percentages, by Type, 2021 (%)
10ml/bottle
40ml/bottle
100ml/bottle
Global Escherichia Coli Trivalent Vaccine for Piglets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Escherichia Coli Trivalent Vaccine for Piglets Market Segment Percentages, by Application, 2021 (%)
Veterinary Pharmacy
Online Sale
Others
Global Escherichia Coli Trivalent Vaccine for Piglets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Escherichia Coli Trivalent Vaccine for Piglets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Escherichia Coli Trivalent Vaccine for Piglets revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Escherichia Coli Trivalent Vaccine for Piglets revenues share in global market, 2021 (%)
Key companies Escherichia Coli Trivalent Vaccine for Piglets sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Escherichia Coli Trivalent Vaccine for Piglets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qilu Animal Health
Shanghai Hile Bio-Technology Co., Ltd.
CAHIC
Shandong Huahong Biological Engineering Co., Ltd.
Zhejiang Nuobewei Biotechnology Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Shandong Binzhou Wohua Biological Engineering Co., Ltd.